Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1357604rdf:typepubmed:Citationlld:pubmed
pubmed-article:1357604lifeskim:mentionsumls-concept:C0036751lld:lifeskim
pubmed-article:1357604lifeskim:mentionsumls-concept:C1882598lld:lifeskim
pubmed-article:1357604lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:1357604lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:1357604lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:1357604pubmed:issue1lld:pubmed
pubmed-article:1357604pubmed:dateCreated1992-11-6lld:pubmed
pubmed-article:1357604pubmed:abstractTextThe purpose of the present study is to clarify the modulation of the biosynthesis of serotonin (5-HT) via the alpha 2-adrenoceptors in the brain. For this purpose, 5-hydroxytryptophan (5-HTP) accumulation was determined using an HPLC-ECD system in the presence of the inhibition of aromatic L-amino acid decarboxylase. Administration of alpha 2-adrenoceptor agonist, clonidine, produced a reduction of the in vivo 5-HTP accumulation in both the rat hippocampus and dorsal raphe nucleus. In addition, alpha 2-adrenoceptor antagonist, idazoxan, increased the 5-HTP accumulation in both the hippocampus and the dorsal raphe nucleus. In rats with catecholaminergic neurons denervated by pretreatment with 6-hydroxydopamine, clonidine failed to produce a reduction of 5-HTP accumulation in the dorsal raphe nucleus. On the other hand, hippocampal 5-HTP accumulation was decreased significantly. Brain tryptophan levels were unaffected by either clonidine or idazoxan. These results suggest that alpha 2-adrenoceptors might modulate serotonin biosynthesis and this modulation might be related to the neuroanatomical differences in the rat brain.lld:pubmed
pubmed-article:1357604pubmed:languageenglld:pubmed
pubmed-article:1357604pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1357604pubmed:citationSubsetIMlld:pubmed
pubmed-article:1357604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1357604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1357604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1357604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1357604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1357604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1357604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1357604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1357604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1357604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1357604pubmed:statusMEDLINElld:pubmed
pubmed-article:1357604pubmed:monthMaylld:pubmed
pubmed-article:1357604pubmed:issn0304-3940lld:pubmed
pubmed-article:1357604pubmed:authorpubmed-author:MatsumotoMMlld:pubmed
pubmed-article:1357604pubmed:authorpubmed-author:SmithC BCBlld:pubmed
pubmed-article:1357604pubmed:authorpubmed-author:SaitoHHlld:pubmed
pubmed-article:1357604pubmed:authorpubmed-author:TogashiHHlld:pubmed
pubmed-article:1357604pubmed:authorpubmed-author:YoshiokaMMlld:pubmed
pubmed-article:1357604pubmed:issnTypePrintlld:pubmed
pubmed-article:1357604pubmed:day11lld:pubmed
pubmed-article:1357604pubmed:volume139lld:pubmed
pubmed-article:1357604pubmed:ownerNLMlld:pubmed
pubmed-article:1357604pubmed:authorsCompleteYlld:pubmed
pubmed-article:1357604pubmed:pagination53-6lld:pubmed
pubmed-article:1357604pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:1357604pubmed:meshHeadingpubmed-meshheading:1357604-...lld:pubmed
pubmed-article:1357604pubmed:meshHeadingpubmed-meshheading:1357604-...lld:pubmed
pubmed-article:1357604pubmed:meshHeadingpubmed-meshheading:1357604-...lld:pubmed
pubmed-article:1357604pubmed:meshHeadingpubmed-meshheading:1357604-...lld:pubmed
pubmed-article:1357604pubmed:meshHeadingpubmed-meshheading:1357604-...lld:pubmed
pubmed-article:1357604pubmed:meshHeadingpubmed-meshheading:1357604-...lld:pubmed
pubmed-article:1357604pubmed:meshHeadingpubmed-meshheading:1357604-...lld:pubmed
pubmed-article:1357604pubmed:meshHeadingpubmed-meshheading:1357604-...lld:pubmed
pubmed-article:1357604pubmed:meshHeadingpubmed-meshheading:1357604-...lld:pubmed
pubmed-article:1357604pubmed:meshHeadingpubmed-meshheading:1357604-...lld:pubmed
pubmed-article:1357604pubmed:meshHeadingpubmed-meshheading:1357604-...lld:pubmed
pubmed-article:1357604pubmed:meshHeadingpubmed-meshheading:1357604-...lld:pubmed
pubmed-article:1357604pubmed:meshHeadingpubmed-meshheading:1357604-...lld:pubmed
pubmed-article:1357604pubmed:meshHeadingpubmed-meshheading:1357604-...lld:pubmed
pubmed-article:1357604pubmed:meshHeadingpubmed-meshheading:1357604-...lld:pubmed
pubmed-article:1357604pubmed:meshHeadingpubmed-meshheading:1357604-...lld:pubmed
pubmed-article:1357604pubmed:year1992lld:pubmed
pubmed-article:1357604pubmed:articleTitleAlpha 2-adrenoceptor modulation of 5-HT biosynthesis in the rat brain.lld:pubmed
pubmed-article:1357604pubmed:affiliationFirst Department of Pharmacology, Hokkaido University School of Medicine, Sapporo, Japan.lld:pubmed
pubmed-article:1357604pubmed:publicationTypeJournal Articlelld:pubmed